Aurobindo Pharma shares were trading at ₹1,226.80 at 11:30 AM on the NSE, down ₹20.40 or 1.64% from the previous close of ₹1,247.20. The stock opened lower at ₹1,238.40 and touched an intraday high of ₹1,244.10, while slipping to a low of ₹1,203.40
According to the company, the fire broke out on April 27 around 10:00 PM, affecting equipment in the coal crusher area of the site. Fortunately, there were no injuries reported, and the core manufacturing infrastructure remains intact.
“The incident caused damage to certain ancillary equipment, but it is not expected to materially impact the group’s operations or financials,” the company stated in a press release dated April 28.
As a precautionary measure, Aurobindo Pharma has temporarily paused operations at the affected plant. The shutdown is expected to last approximately 20 to 25 days to allow for equipment replacement and safety checks. The company also confirmed that the facility is fully insured.
“We are committed to resuming full operations swiftly, while maintaining the highest safety and quality standards,” the company added.
Despite the recent dip in Aurobindo Pharma’s share price, the company’s long-term performance reflects strong resilience. Over the past month, the stock has gained 4%, showcasing short-term momentum.
However, on a year-to-date (YTD) basis, it has declined by 10%, largely due to intermittent operational challenges. Looking at a broader horizon, the stock has delivered a modest 5% return over the past year and an impressive 92% gain over the last three years.
Read More: SEBI Mandates Brokers to Collect Margins by T+1 Settlement Cycle.
While the fire incident at Aurobindo Pharma’s Andhra Pradesh facility caused a temporary setback, the company’s swift action and assurance of minimal financial impact have helped maintain investor confidence. Its strong long-term stock performance highlights the company’s resilience and operational strength.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Apr 29, 2025, 11:40 AM IST
Neha Dubey
Neha Dubey is a Content Analyst with 3 years of experience in financial journalism, having written for a leading newswire agency and multiple newspapers. At Angel One, she creates daily content on finance and the economy. Neha holds a degree in Economics and a Master’s in Journalism.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates